phosphoribosyl pyrophosphate has been researched along with 3-deazauridine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Abreu, RA; Mooyer, PA; Stet, EH; van Berg, AA; van Gennip, AH; van Kuilenburg, AB; van Lenthe, H | 1 |
1 other study(ies) available for phosphoribosyl pyrophosphate and 3-deazauridine
Article | Year |
---|---|
The IMP dehydrogenase inhibitor mycophenolic acid antagonizes the CTP synthetase inhibitor 3-deazauridine in MOLT-3 human leukemia cells: a central role for phosphoribosyl pyrophosphate.
Topics: 3-Deazauridine; Carbon-Nitrogen Ligases; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; IMP Dehydrogenase; Leukemia; Ligases; Mycophenolic Acid; Phosphoribosyl Pyrophosphate; Ribonucleotides; Tumor Cells, Cultured | 1995 |